...
首页> 外文期刊>Neuropharmacology >The selective 5-HT6 receptor antagonists SB-271046 and SB-399885 potentiate NCAM PSA immunolabeling of dentate granule cells, but not neurogenesis, in the hippocampal formation of mature Wistar rats.
【24h】

The selective 5-HT6 receptor antagonists SB-271046 and SB-399885 potentiate NCAM PSA immunolabeling of dentate granule cells, but not neurogenesis, in the hippocampal formation of mature Wistar rats.

机译:选择性5-HT6受体拮抗剂SB-271046和SB-399885增强了成熟Wistar大鼠海马形成中齿状颗粒细胞的NCAM PSA免疫标记,但不增强神经发生。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

While there is now substantial evidence that 5-HT(6) antagonism leads to significantly improved cognitive ability, the mechanism(s) and/or pathway(s) involved are poorly understood. We have evaluated the consequence of chronic administration of the 5-HT(6) receptor antagonists SB-271046 and SB-399885 on neural cell adhesion molecule polysialylation state (NCAM PSA), a neuroplastic mechanism necessary for memory consolidation. Quantitative analysis of NCAM PSA immunopositive neurons in the dentate gyrus of drug-treated animals revealed a dose-dependent increase in polysialylated cell frequency following treatment with both SB-271046 and SB-399885. These effects could not be attributed to increased neurogenesis, as no difference in the rate of bromodeoxyuridine incorporation was apparent between the control and drug-treated groups. A substantial increase in the frequency of polysialylated cells in layer II of the entorhinal and perirhinal cortices was also observed, brain regions not previously associated with neurogenesis. Chronic treatment with SB-271046 or SB-399885 also significantly increased the activation of dentate polysialylation that is specific to learning. This effect does not occur with other cognition-enhancing drugs, such as tacrine, and this action potentially differentiates 5-HT(6) receptor antagonism as an unique neuroplastic mechanism for cognitive processes which may slow or reverse ageeurodegenerative related memory deficits.
机译:尽管现在有大量证据表明5-HT(6)拮抗作用可显着提高认知能力,但所涉及的机制和/或途径知之甚少。我们已经评估了对神经细胞粘附分子多唾液酸化状态(NCAM PSA),记忆巩固所必需的神经塑性机制的5-HT(6)受体拮抗剂SB-271046和SB-399885的长期给药的后果。药物治疗动物的齿状回中NCAM PSA免疫阳性神经元的定量分析显示,用SB-271046和SB-399885处理后,多唾液酸化细胞频率呈剂量依赖性增加。这些作用不能归因于神经发生的增加,因为对照组和药物治疗组之间的溴脱氧尿苷掺入速率没有明显差异。还观察到内嗅和皮层皮质第二层中多唾液酸化细胞的频率显着增加,大脑区域以前与神经发生无关。 SB-271046或SB-399885的慢性治疗也显着增加了学习所特有的齿状聚唾液酸化的激活。使用其他认知增强药物(例如他克林)不会发生这种作用,并且这种作用可能会将5-HT(6)受体拮抗作用区分为认知过程的独特神经塑性机制,从而可能减慢或逆转与年龄/神经退行性疾病相关的记忆缺陷。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号